Selpercatinib will expand treatment options available for people with RET fusion positive non small cell lung cancer on the NHS in England.
We spoke to Dr Ishu Kataria who works with WHO to prevent the spread of infections like HPV, which causes 99% of cervical cancers worldwide.
We caught up with Director of Research, Dr Catherine Elliott, to talk pandemic recovery, research careers and the role of curiosity in a goal driven scientific environment
The picture is still emerging and we don’t have a full sense yet of what each announcement will mean, but broadly it looks promising. Here’s what we know right now.
The targeted drug olaparib has been approved for some people with a type of advanced prostate cancer on the NHS in Scotland.
We spoke to 4 people about why, when it comes to cancer, every second counts and why the Government must act now to ensure the NHS can catch more cancers early.
A study published earlier this year uncovered some important differences in people’s experience of visiting the GP.
In the last 6 years, almost 55,000 cancer patients should have been diagnosed or started their treatment sooner, according to new calculations.